VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,249,145 | -11.5% | 306,546 | -0.9% | 0.03% | -5.9% |
| Q2 2023 | $9,317,470 | -10.1% | 309,448 | -3.5% | 0.03% | -17.1% |
| Q1 2023 | $10,368,877 | +24.3% | 320,522 | +10.2% | 0.04% | +13.9% |
| Q4 2022 | $8,339,134 | +32.6% | 290,968 | +11.6% | 0.04% | +24.1% |
| Q3 2022 | $6,288,000 | -11.1% | 260,717 | +0.9% | 0.03% | -6.5% |
| Q2 2022 | $7,074,000 | -30.0% | 258,367 | -1.9% | 0.03% | -11.4% |
| Q1 2022 | $10,101,000 | +19.5% | 263,400 | -0.2% | 0.04% | +29.6% |
| Q4 2021 | $8,451,000 | +7.9% | 263,835 | -0.7% | 0.03% | 0.0% |
| Q3 2021 | $7,830,000 | -10.5% | 265,702 | +3.2% | 0.03% | -10.0% |
| Q2 2021 | $8,746,000 | +6.3% | 257,375 | +1.7% | 0.03% | -3.2% |
| Q1 2021 | $8,224,000 | -8.0% | 253,059 | +1.9% | 0.03% | -6.1% |
| Q4 2020 | $8,943,000 | -1.0% | 248,265 | +7.7% | 0.03% | -13.2% |
| Q3 2020 | $9,031,000 | +7.5% | 230,615 | +0.7% | 0.04% | -5.0% |
| Q2 2020 | $8,404,000 | +98.0% | 229,115 | +24.4% | 0.04% | +48.1% |
| Q1 2020 | $4,244,000 | -15.0% | 184,217 | +8.0% | 0.03% | +3.8% |
| Q4 2019 | $4,995,000 | +7.4% | 170,610 | -2.0% | 0.03% | -3.7% |
| Q3 2019 | $4,650,000 | +1.8% | 174,103 | -2.6% | 0.03% | +3.8% |
| Q2 2019 | $4,569,000 | +59.8% | 178,766 | +40.1% | 0.03% | +52.9% |
| Q1 2019 | $2,860,000 | +15.7% | 127,562 | +8.9% | 0.02% | -5.6% |
| Q4 2018 | $2,471,000 | -12.5% | 117,177 | -23.2% | 0.02% | +5.9% |
| Q3 2018 | $2,825,000 | -42.7% | 152,544 | -31.0% | 0.02% | -50.0% |
| Q2 2018 | $4,930,000 | -3.2% | 220,970 | -4.6% | 0.03% | -5.6% |
| Q1 2018 | $5,094,000 | +61.2% | 231,741 | +70.4% | 0.04% | +71.4% |
| Q4 2017 | $3,161,000 | +85.8% | 136,000 | +83.6% | 0.02% | +61.5% |
| Q3 2017 | $1,701,000 | -54.2% | 74,073 | -56.0% | 0.01% | -53.6% |
| Q2 2017 | $3,715,000 | -10.9% | 168,235 | -7.9% | 0.03% | -17.6% |
| Q1 2017 | $4,171,000 | +37.7% | 182,675 | +26.1% | 0.03% | +25.9% |
| Q4 2016 | $3,030,000 | +64.7% | 144,852 | +108.0% | 0.03% | +68.8% |
| Q3 2016 | $1,840,000 | +3.5% | 69,632 | +8.6% | 0.02% | -5.9% |
| Q2 2016 | $1,777,000 | – | 64,132 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |